ArticleMaterials (Basel, Switzerland)2025
Synthesis and Characterization of Biodegradable Terpolymer Scale Inhibitors.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
To address scaling issues in oilfield water injection, a degradable terpolymer scale inhibitor MA-AA-AMPS (terpolymer)was synthesized via aqueous solution polymerization using maleic anhydride, acrylic acid, and 2-acrylamido-2-methylpropanesulfonic acid as monomers. Characterization confirmed the presence of carboxyl, sulfonic, and amide groups in the copolymer with good thermal stability. Scale inhibition tests showed that at 2% dosage, its scale inhibition efficiency exceeded 80%, remaining above 80% in the pH range of 3-8 and over 50% at 150 °C, with excellent tolerance to high-calcium environments. Biodegradation tests revealed BOD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.